This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zeria Pharmaceutical Co., Ltd.
Drug Names(s): Promac (JP)
Description: Z-103 serves as a zinc replacement therapy. Studies in murine models have shown an improvement of the decrease in taste bud proliferation caused by zinc deficiency.
Zeria and SK Chemicals
In February 2006, SK Chemicals announced that they signed a contract with Zeria for the introduction of PROMAC (polaprezinc) for the treatment of gastritis and gastric ulcers through immuno-modulating and anti-inflammatory actions into the South Korean market.
Partners: SK Chemicals Co., Ltd.
Additional information available to subscribers only: